This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Syneron Medical's CEO Hosts Investor Meeting Conference (Transcript)

Syneron Medical Ltd. (ELOS)

Investor Meeting Conference Call

May 22, 2012 10:30 am ET

Executives

Louis P. Scafuri – Chief Executive Officer

Alan Gold – Plastic Surgeon, Great Neck

Shimon Eckhouse – Chairman

Christopher Inglefield – Medical Director and Owner, London Bridge Plastic Surgery & Aesthetic Clinic

Arie Benchetrit – Cosmedica Plastic Surgery Clinic

Fabian Tenenbaum – Chief Executive Officer, Syneron Beauty

Zoe Diana Draelos – Dermatologist, High Point

Presentation

Louis P. Scafuri



Good morning my name is Louis Scafuri, I’m the Chief Executive Officer of Syneron on behalf of our company I would like to welcome everyone to our investor presentation today. Joining me today from Syneron management is our Chairman and Founder Dr. Shimon Eckhouse also our Chief Financial Officer Mr. Asaf Alperovitz. As well as we are joined by Mr. Fabian Tenenbaum who is the Chief Executive Officer of Syneron Beauty and Assaf Korner, who is the CFO. So we have during our breakout session of various intervals today we have the ability to talk and interact with people if you have any specific questions related to the company.

We’ve led on our interactive meeting today we have some guest speakers that have traveled some distance to get here. And we will in our presentation today contain some forward-looking statements as well. As far as today’s agenda we are going to try to keep things on schedule. I will start with a basic overview of the company followed by our guest speakers and I would like to introduce our guest speakers briefly today.

1 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs